IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Logos Global Management LP

Portfolio Profile

CIK: 0001792126 | San Francisco, CA

Investment Profile

Style

Value

Turnover

Very High

Orientation

Concentrated trader
$2.3B
AUM
68
Positions
48.35%
Top 10 Conc.
77.69%
Top 25 Conc.

Top Holdings

#SecuritySharesValue% of Portfolio
1Erasca Inc(ERAS)12,150,000$222.6M9.58%
2Abivax SA(ABVX)1,024,000$136.5M5.87%
3Revolution Medicines Inc(RVMD)700,000$131.1M5.64%
4Ideaya Biosciences Inc(IDYA)3,000,000$111.8M4.81%
5Biontech SE(BNTX)1,015,000$94.4M4.07%
6

Sector Allocation

Latest filing, equity positions only

Healthcare97.07% · $2.3B
Unclassified2.93% · $68.1M

Sector Rotation

Quarter-over-quarter weight changes

SectorPrev %Curr %Change
Healthcare98.4%97.07%-1.33%
Unclassified1.6%2.93%+1.33%

Cap Size Rotation

Quarter-over-quarter weight changes by market cap

AUM History

$749.5M | 56 pos.
$1.1B | 53 pos.
$1.2B | 57 pos.
$1.2B | 57 pos.
$926.8M | 55 pos.
$854.6M | 47 pos.
Vera Therapeutics Inc(VERA)
2,200,000
$94.4M
4.06%
7Tango Therapeutics Inc(TNGX)2,850,000$89.1M3.84%
8Praxis Precision Medicines I(PRAX)260,000$87.0M3.75%
9Celldex Therapeutics Inc New(CLDX)2,100,000$78.1M3.36%
10Dianthus Therapeutics Inc(DNTH)800,000$78.0M3.36%
Cap SizePrev %Curr %Change
Mid Cap59.54%54.96%-4.58%
Small Cap21.11%26.82%+5.71%
Large Cap16.64%10.56%-6.08%
Micro Cap1.11%4.72%+3.61%
Unclassified1.6%2.93%+1.33%
$562.5M | 39 pos.
$903.8M | 51 pos.
$1.1B | 59 pos.
$1.7B | 69 pos.
$2.0B | 66 pos.
$2.3B | 68 pos.
Q3
23
Q4
23
Q1
24
Q2
24
Q3
24
Q4
24
Q1
25
Q2
25
Q3
25
Q4
25
Q1
26
Q2
26

Recent Activity

Quarter-over-quarter position changes

25
New
23
Closed
18
Increased
19
Decreased
6
Unchanged